Outcome of Laparoscopic and Robotic Assisted Laparoscopic Radical Prostatectomy in High-risk Localized Prostate Cancer
Keywords:LRP, RALP, High risk localized prostate cancer
AbstractBackground: The treatment for high risk localized prostate cancer patients still have controversial among radiotherapy (RT), androgen deprivation therapy (ADT) and radical prostatectomy (RP).
Objectives: To study outcome of laparoscopic radical prostatectomy (LRP) and robotic assisted laparoscopic radical prostatectomy (RALP) in high risk localized prostate cancer patients.
Methods: In a retrospective descriptive analytic study from March 2005 to December 2009, 309 patients with prostate specific antigen (PSA) >20 ng/ml or Gleason score (GS) 8-10 points or Clinical T3a underwent LRP or RALP by 6 urologists. Preoperative, intraoperative and postoperative data were analyzed.
Results: The mean of age was 68.1+7.6 years old. The median of PSA was 26.27 (0.44-300) ng/ml. 48.9% of patients had GS 8-10 and 42.7% had clinical T3a. There were 61 patients (20.1%) receiving neoadjuvant ADT. 185 patients (59.8%) underwent LRP and 124 patients (40.2%) underwent RALP. The mean of operative time was 246.5+82.8 min with the median of blood loss 550 ml. (50-3,200 ml.). There was neither mortality nor converted operation to opened RP. 87 (28.3%) patients had morbidity after LRP and RALP with intraoperative complications; bleeding 17.9%, rectal injury 0.9% and nerve injury 0.3%, Postoperative complications; cardiovascular disease 10.7%, anastomotic leakage 10.4%, hematoma 3.2%, prolong lymph drainage 2.6%, bowel ileus 1.6%, pneumonia 0.9%, thromboembolism 0.3% and wound infection 0.3%. The mean of followup was 36.0+16.2 mo. There were late complications; anastomotic stricture 1.8% and one patient died from lung cancer. For pathological outcome, all patients had Adenocarcinoma with pGS7 47.7% and pGS8-10 47.7%.There were patients having pathological stage T3 62.3% and no lymph node metastasis 87.3%. 189 patients (61.7%) had positive margins. 5-yr Biochemical Progression-free survival (BPFS) was at 74.3%.
Conclusions: RALP is one of effective choice for treatment patients with high risk localized prostate cancer due to no mortality and minor complications.
Download data is not yet available.
How to Cite
Im-oepsin, S., Nualyong, C., Leewansangtong, S., Taweemonkongsap, T., Amornvesukit, T., Chotikawanich, E., Soontrapa, S., Tantiwong, A., Sujijantararat, P., & Srinualnad, S. (2012). Outcome of Laparoscopic and Robotic Assisted Laparoscopic Radical Prostatectomy in High-risk Localized Prostate Cancer. Insight Urology, 33(2), 106–115. Retrieved from https://he02.tci-thaijo.org/index.php/TJU/article/view/63157